Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

BBNXBBNX
6 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in BETA BIONICS INC

Yes. Geode Capital Management holds 1,073,452 shares of BBNX (Beta Bionics), worth $16.8M, as of its Q2 2026 13F filing. It increased the position by 140,774 shares (+15.1%) from Q1 2026. Geode Capital Management has held BBNX in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$16.8M

Current Shares

1.1M

Total Value Change

+$13.1M

Total Shares Change

+767,435

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+15.1%
$16.8M0.0%$15.67
32
2026-Q1
Increased
932,678
+1.2%
$9.3M0.0%$11.57
28
2025-Q4
Increased
921,464
+0.4%
$28.1M0.0%$31.97
29
2025-Q3
Increased
917,553
+193.2%
$18.2M0.0%$19.85
46
2025-Q2
Increased
312,930
+2.3%
$4.6M0.0%$15.07
27
2025-Q1
New
306,017
-
$3.7M0.0%$11.71
37

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used